ReVision Implant, a Belgian neurotechnology firm, has closed an oversubscribed €4 million funding round, marking a significant milestone as they transition to clinical and operational expansion. This funding, supported by existing and new private investors including European business leaders and medtech operators, will be used to expand their team, advance regulatory compliance, and scale their clinical program. The company is also investing in its own cleanroom infrastructure to bring manufacturing in-house and further product development.